Kelun-Biotech Advances SKB575 with China IND Approval
CHENGDU, China, July 15, 2026 Kelun-Biotech and Harbour BioMed have announced that China’s National Medical Products Administration (NMPA) has...
FDA IND Clearance
Advertisement
MAXONA Wins FDA IND Clearance for MAX-001 Phase 2 Trial
MALVERN, Pa., July 15, 2026 MAXONA Pharmaceuticals has received U.S. FDA Investigational New Drug (IND) clearance to initiate a...
Akeso Opens U.S. Phase II Trial for PD-1/CTLA-4 Bispecific
HONG KONG, July 14, 2026 Akeso, Inc. has announced the launch of a Phase II clinical trial in the...
HitGen Partner BioAge Launches Phase II Trial for BGE-102
CHENGDU, China, July 14, 2026 HitGen Inc. has announced that its partner BioAge Labs has dosed the first participant...
Atrium Therapeutics Launches Phase 1/2 Trial for ATR 1072
SAN DIEGO, Calif., July 14, 2026 Atrium Therapeutics has achieved an important regulatory milestone after the U.S. Food and...
Advertisements
Imviva Biotech Advances CTA313 CAR-T Program with FDA IND Approval
BOSTON, June 9, 2026 Imviva Biotech announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational...
Pentixapharm Advances PANDA Phase 3 Study After FDA Clearance
BERLIN, Germany – June 9, 2026 Pentixapharm Holding AG has achieved a major regulatory milestone after receiving U.S. Food...
Harbour BioMed Receives FDA IND Clearance for HBM7004 Solid Tumor Trial
CAMBRIDGE, Massachusetts, ROTTERDAM, Netherlands, and SHANGHAI, China, May 8, 2026 Harbour BioMed announced that the U.S. Food and Drug...
BRC Therapeutics Secures FDA IND Clearance for BRC-002 Therapy
MONTEREY, California, USA, April 28, 2026 BRC Therapeutics has announced that the U.S. Food and Drug Administration has cleared...
CU Anschutz Secures FDA IND for CAR T-Cell Therapy
AURORA, Colo., April 2, 2026 The University of Colorado Anschutz Medical Campus Gates Institute announced it has received U.S....
Advertisement
